ArticleThe journal of prevention of Alzheimer's disease2026
The generalizability gap: anticoagulant exclusions and the "Enhanced Safety" of donanemab in the EU-eligible population.
Azan Ijaz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.